Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The UK's Fastest-Growing Fertility Clinic Begins International Expansion, Bringing the World's Most Digitally Advanced AI-Powered Fertility Model to Brazil

This image opens in the lightbox

News provided by

AVENUES

06 Jul, 2026, 09:03 GMT

Share this article

Share toX

Share this article

Share toX

Avenues expands internationally through a strategic partnership with Brazil's leading fertility experts.

LONDON and SÃO PAULO, July 6, 2026 /PRNewswire/ -- Avenues, the UK's fastest-growing fertility clinic, today announced the launch of Avenues Brazil in São Paulo, marking the company's first international expansion and the next step in its mission to make world-class fertility care more accessible through artificial intelligence, digital innovation and compassionate care.

Only two years after opening its flagship clinic in London, Avenues has become the UK's fastest-scaling fertility provider and is preparing to open its second UK clinic in Cambridge in autumn. Now, through a strategic partnership with four of Brazil's most respected leaders in reproductive medicine, the company is bringing its pioneering model of care to Latin America.

Built to Scale Compassion Without Compromising Quality

When Dr Cristina Hickman founded Avenues in January 2024, the ambition was never simply to build another IVF clinic. It was to create a new blueprint for fertility care, one that combines world-leading embryology, artificial intelligence, robotics, complete digitalisation and compassionate care into a model that can be replicated globally without compromising quality.

Purpose-built from the ground up, every Avenues clinic operates on a fully digital platform that captures more clinical and operational data than any IVF clinic worldwide. Artificial intelligence supports clinicians by reducing administrative burden, optimising laboratory and clinical workflows, personalising patient care and continuously improving decision making. The result is a more efficient clinic, a better patient experience and greater access to high-quality fertility treatment.

Its modular clinic design enables rapid expansion while maintaining identical clinical standards across every location, allowing Avenues to scale without compromising the quality of care that defines the brand. That vision has translated into unprecedented growth.

Since opening in 2024, Avenues has experienced unprecedented growth, now performing approximately 170 egg collections every month, more than 2,000 annually, making it one of the UK's largest private fertility clinics by treatment volume. The clinic has reached a scale achieved by only a handful of established fertility centres, most of which have taken decades to reach this level, while Avenues has delivered year-on-year growth of more than 227%..

Benchmarking against HFEA-registered clinic data suggests that no UK private fertility clinic has documented a comparable growth rate.

"Our ambition was never to build one exceptional clinic," said Dr Cristina Hickman, Founder of Avenues, the 13th IVF clinic she built. "It was to build a model capable of bringing exceptional fertility care to millions more people. Technology should never replace compassion, it should amplify it. By removing inefficiencies, giving clinicians better information and creating a truly connected patient journey, we can deliver better care, better outcomes and make fertility treatment more accessible. Brazil is the first step in building a global network of AI-enabled fertility centres."

A Partnership Built on Shared Excellence

Brazil is recognised internationally for excellence in reproductive medicine, with a long history of scientific innovation and clinical leadership.

Avenues Brazil brings together four highly respected leaders whose expertise spans clinical care, embryology, laboratory science, healthcare innovation and operational excellence.

  • Dr Edson Lo Turco | internationally recognised reproductive scientist and embryologist with more than 25 years of experience leading innovation, research and laboratory excellence in assisted reproduction.
  • Bernardo Lamounier de Moura | healthcare entrepreneur, clinical embryologist and fertility executive specialising in laboratory operations, governance and scaling high-performing reproductive medicine organisations.
  • Dr Luis Balducci | leading reproductive physician specialising in assisted reproduction, fertility preservation and complex fertility care.
  • Fernando Prado Ferreira | CEO with more than 13 years of leadership experience driving innovation, digital transformation and strategic growth in reproductive healthcare.

Together, they will combine Brazilian clinical excellence with Avenues' AI-native operating platform to create one of Latin America's most technologically advanced fertility centres.

"Brazil has some of the world's finest reproductive specialists," said Fernando Prado Ferreira. "Avenues has developed one of the world's most advanced fertility platforms. Bringing those strengths together gives us an extraordinary opportunity, not simply to open another clinic, but to redefine what patients should expect from fertility care. Together, we will build care where technology enhances every decision at every interaction and every patient journey."

Dr Hickman added:

"Nearly fifty years ago, IVF transformed medicine forever. We believe artificial intelligence will transform how that medicine is delivered over the next fifty. This is not about replacing people with technology. It is about giving exceptional clinicians the tools they need to spend more time caring for patients while intelligent systems continuously improve every part of the patient journey. Our goal is simple: to make outstanding fertility care more accessible and more personal for families around the world."

About Avenues

Founded in London in 2024 by Dr Cristina Hickman, Avenues is redefining fertility care through artificial intelligence, complete digital transformation and world-leading reproductive science.

The HFEA-licensed clinic has become the UK's fastest-growing fertility clinic by treatment volume and the first to integrate AI throughout the entire patient journey. Its unique combination of intelligent technology, compassionate care, modular clinic design and advanced embryology is creating a scalable model for the future of fertility treatment.

Following the success of its flagship London clinic, Avenues is expanding across the United Kingdom and internationally,  with its second UK clinic opening in Cambridge in autumn 2026,  while Avenues Brazil marks Avenues' first international partnership.

Modal title

Also from this source

AVENUES: FROM FERTILISATION FAILURE TO FATHERHOOD, GLOBAL FIRST ACHIEVED BY AI-POWERED FERTILITY CLINIC

AVENUES: FROM FERTILISATION FAILURE TO FATHERHOOD, GLOBAL FIRST ACHIEVED BY AI-POWERED FERTILITY CLINIC

A couple previously told their only route to parenthood was sperm donation are now expecting a baby of their own, following a world-first fertility...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Computer & Electronics

Computer & Electronics

Artificial Intelligence

Artificial Intelligence

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.